[Skip to Content]
[Skip to Content Landing]
Research Letter
September 2017

Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015

Author Affiliations
  • 1Surveillance & Health Services Research, American Cancer Society, Atlanta, Georgia
JAMA Oncol. 2017;3(9):1278-1281. doi:10.1001/jamaoncol.2016.6416

Lung cancer is the most preventable and leading cause of cancer deaths in the United States, with about 155 870 deaths each year.1 In December 2013, the United States Preventive Services Task Force (USPSTF) recommended annual screening for lung cancer with low-dose computed tomography (LDCT) for asymptomatic persons aged 55 to 80 years who have a 30 pack or more per year smoking history and currently smoke or have quit within the past 15 years.2 According to the 2010 National Health Interview Survey (NHIS), only 2% to 4% of high-risk smokers received LDCT for lung cancer screening in the previous year.3 In this study, we examined whether LDCT screening has increased following the USPSTF recommendation.

First Page Preview View Large
First page PDF preview
First page PDF preview